Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Nippon Fine Chemical, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2%, Oct-Dec Ordinary Profit Decreases by 33%
4362 Nippon Fine Chemical Co., Ltd. 【J-GAAP】
Earnings ReportNippon Fine Chemical Co., Ltd. <4362> [TSE Prime] announced its financial results after the market closed on January 28th (16:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) was 4.10 billion yen, a 1.8% increase compared to the same period last year. However, Progress toward the full-year plan of 5.73 billion yen was 71.6%, also falling below the five-year average of 77.3%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to expand 38.1% from the same period last year, reaching 1.62 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit dropped to 1.00 billion yen, a 33.1% decrease compared to the same period last year. The operating profit margin decreased from 14.6% in the same period last year to 11.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 24,302 | 2,963 | 3,246 | 2,298 | 100.8 | 72.9 | Jan 30, 2024 | J-GAAP |
| Apr - Dec, 2024 | 26,610 | 3,749 | 4,033 | 2,805 | 124.7 | 77.4 | Jan 29, 2025 | J-GAAP |
| Apr - Dec, 2025 | 24,879 | 3,846 | 4,105 | 3,453 | 157.4 | 71.6 | Jan 28, 2026 | J-GAAP |
| YoY | -6.5% | +2.6% | +1.8% | +23.1% | +26.2% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 18,285 | 2,495 | 2,677 | 2,077 | 92.3 | 37 | Apr 30, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 17,505 | 2,520 | 2,629 | 1,993 | 91.9 | 47 | Oct 31, 2025 | J-GAAP |
| YoY | -4.3% | +1.0% | -1.8% | -4.0% | -0.5% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 33,531 | 4,197 | 4,452 | 3,327 | 146.4 | 70 | Apr 30, 2024 | J-GAAP |
| Mar, 2025 | 35,663 | 4,895 | 5,210 | 3,870 | 172.1 | 74 | Apr 30, 2025 | J-GAAP |
| Mar, 2026 Guidance | 35,000 | 5,500 | 5,730 | 4,500 | 207.5 | 94 | Oct 31, 2025 | J-GAAP |
| YoY | -1.9% | +12.4% | +10.0% | +16.3% | +20.6% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 9,232 | 1,349 | 1,500 | 1,012 | 45.0 | 14.6 | Jan 29, 2025 | J-GAAP |
| Jan - Mar, 2025 | 9,053 | 1,146 | 1,177 | 1,065 | 47.4 | 12.7 | Apr 30, 2025 | J-GAAP |
| Apr - Jun, 2025 | 8,121 | 1,238 | 1,390 | 999 | 44.8 | 15.2 | Jul 30, 2025 | J-GAAP |
| Jul - Sep, 2025 | 9,374 | 1,742 | 1,711 | 1,508 | 68.3 | 18.6 | Oct 31, 2025 | J-GAAP |
| Oct - Dec, 2025 | 7,384 | 866 | 1,004 | 946 | 43.1 | 11.7 | Jan 28, 2026 | J-GAAP |
| YoY | -20.0% | -35.8% | -33.1% | -6.5% | -4.2% |
Related Articles
DKS, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 20%, Raises Record High Profit Forecast, Dividend Revised Upward by 10 Yen
Nikkei 225 close on the 28th = rising, 25 yen higher to 53,358 yen
OXIDE, Net Income Forecast for the Fiscal Year Revised Downward to a Loss
JCR Pharma, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 83%
FUJI OOZX, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 21%, Oct-Dec Ordinary Profit Decreases by 20%
NIHON KOGYO, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 5%
MURAKI, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 10%, Exceeds Full-Year Plan
MORESCO, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 29%, Dividend Revised Upward by 10 Yen
Cocolonet, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 10%, Oct-Dec Ordinary Profit Decreases by 19%
Daito Chemix, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 12%